NCT01817725View on ClinicalTrials.gov

Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Chronic Hepatitis B
Interventions
BIOLOGICAL

HBV vaccine (Engerix B)

Engerix-B (20μg/ml, GlaxoSmithKline Biologicals) is administered intramuscularly at 0, 2, 4, 6, 8, 10, 12 months. The dosage will be 20μg in those \<= 20 years old and 40μg in those \> 20 years old.

Trial Locations (1)

33305

Chang Gung Memorial Hospital, Taoyuan Xian

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT01817725 - Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg | Biotech Hunter | Biotech Hunter